Britian has jumped the gun on gene editing
By Donna Dickenson,
Telegraph [UK]
| 02. 02. 2016
Untitled Document
For the first time Britain’s Human Fertilisation and Embryology Authority (HFEA) has granted researchers permission to use a new “gene editing” technique called Crispr/Cas9 to modify human embryos. This is despite a global summit held last December by the National Academies of Science in Washington which warned that, when it comes to this powerful new technique, no nation should go it alone. Other countries such as the United States are just as advanced as Britain in gene editing – indeed, the techniques authorised by HFEA were partly developed in America. But these nations are, rightly, being more cautious in using it.
Why? Their objections do not rest on religion or Luddite opposition to new technology. And it is not gene editing per se – they have fewer concerns about the technique’s use to correct genetic problems in individual living patients. But around the world, expert scientists and bioethicists are worried about its use to modify human embryos. If such embryos are reimplanted in the womb and born, genetic modifications would not be confined to them, but passed down...
Related Articles
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By Amy Feldman, Forbes | 02.17.2026
"Jennifer Doudna" by Duncan Hull for the Royal Society via Wikimedia Commons licensed under CC by SA 3.0
Soon after KJ Muldoon was born in August 2024, he was lethargic and wouldn’t eat. His worried doctors realized his ammonia...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...